Balance, Mr. Tibbs, Tatonkano: Thanks for your support/kind words. I know the post in question was a bash, of sorts. But actually I am not that down on the stock, despite it retreating under $1.00 again. After the announcement last week about the newest agreement with another University, I was just curious how many of those "research collaboration agreements" the company had entered into in the past. It is research on the cheap. The company gives the University professor some money, typically $50,000, and the professor and his graduate students conduct the research in their spare time. If they are skillful and/or lucky enough to get some nice results, they write an article and try to get it published in a peer reviewed journal. The professors would try to discourage earlier dissemination of the research, because that lessens the possibility of being published.. Most journals do not like to publish "old news." There is a huge backlog for publishing such research articles. It could take years. The professor's interest (publish or perish) do not always correspond with the sponsoring company's interest. In all reality it is a step in creating the appearance of progress. And that is all it has been for CYGX. It is the company's woeful financial situation that prevents it from conducting much of this research in-house. They simply do not have the funds to hire a sufficient nember of scientists to move forward as fast as we would all like. The trouble with this is that other companies are not standing still. Still, the recent hire of the guy to head up the syn-DNA production facility give me hope. I wish the rest of the investment public shared that hope. Then we wouldn't be back under a buck.
